Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableStudy completedNCT07611201
What this trial is testing

The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior

Who this might be right for
ObesityOverweightTaste Perception+3 more
Purdue University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06967558
What this trial is testing

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

Who this might be right for
PreDiabetes
Mayo Clinic 60
Early research (Phase 1)Study completedNCT02692040
What this trial is testing

Study of the Gut Hormone Analogue G3215 in Adult Subjects

Who this might be right for
Diabetes MellitusObesity
Imperial College London 90
Early research (Phase 1)Ended earlyNCT03645408
What this trial is testing

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Who this might be right for
Alcohol Use Disorder
Boston Medical Center 8
Not applicableLooking for participantsNCT07732738
What this trial is testing

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

Who this might be right for
Obesity
China-Japan Friendship Hospital 400
Large-scale testing (Phase 3)Study completedNCT00747968
What this trial is testing

The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET

Who this might be right for
Type 2 Diabetes
University of Aarhus 8
Not applicableStudy completedNCT01374594
What this trial is testing

Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients

Who this might be right for
Diabetes
University Hospital, Gentofte, Copenhagen 30
Not applicableStudy completedNCT00603031
What this trial is testing

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

Who this might be right for
Type-1 Diabetes Mellitus
Hvidovre University Hospital 9
Post-approval studies (Phase 4)Looking for participantsNCT07127354
What this trial is testing

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Who this might be right for
GLP - 1Bowel Preparation for Colonoscopy
The Cleveland Clinic 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386
What this trial is testing

Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 90
Post-approval studies (Phase 4)Study completedNCT02738151
What this trial is testing

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 929
Large-scale testing (Phase 3)Looking for participantsNCT07282041
What this trial is testing

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Who this might be right for
Intracranial AtherosclerosisStroke, Ischemic
National University of Singapore 130
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Post-approval studies (Phase 4)UnknownNCT04146155
What this trial is testing

Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

Who this might be right for
Type 2 DiabetesPeripheral Vascular Disorder Due to Diabetes Mellitus
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Not applicableUnknownNCT05705388
What this trial is testing

POSE2.0 With GLP-1 Agonist for Obesity Management

Who this might be right for
Obesity
Emirates Health Services (EHS) 50
Not applicableNot Yet RecruitingNCT07130396
What this trial is testing

Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

Who this might be right for
GLP-1Adults
Metagenics, Inc. 100
Not applicableLooking for participantsNCT07229170
What this trial is testing

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Who this might be right for
Obesity & OverweightTaste AlterationsWeight Loss+1 more
San Raffaele Telematic University 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07411378
What this trial is testing

Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Who this might be right for
Muscle WastingObesity & OverweightObesity
Biophytis 164
Not applicableLooking for participantsNCT04174755
What this trial is testing

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

Who this might be right for
ObesityHIV-1-infection
University College Dublin 80
Next Page